FDA Adverse Event Malfunction Summary report: N

BINAXNOW STREP PNEUMONIAE 22T (LFR)

MDR report key: 18678381 · Received February 9, 2024

Report

Report Number
1221359-2024-00163
Event Type
Malfunction
Date Received
February 9, 2024
Date of Event
January 1, 2024
Report Date
February 9, 2024
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
GTZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GB
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. B3: THE DATE PROVIDED IS AN APPROXIMATION AS THE EXACT EVENT DATE WAS NOT PROVIDED THE REQUIRED INTAKE INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND / UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL. IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUES AS NO INFORMATION WAS PROVIDED FOR INVESTIGATION. H3 OTHER TEXT : SINGLE USE; DEVICE DISCARDED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED AN UNSPECIFIED NUMBER OF FALSE RESULTS WITH THE BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD PERFORMED ON AN UNKNOWN DATE ON AN UNKNOWN SAMPLE TYPE. NO ADDITIONAL TEST INFORMATION, INCLUDING IF THE PATIENT RESULTS WERE FALSE POSITIVE OR NEGATIVE RESULTS, WAS PROVIDED. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1338860 BINAXNOW STREP PNEUMONIAE 22T (LFR) ANTISERA, ALL GROUPS, STREPTOCOCCUS SPP. GTZ ABBOTT DIAGNOSTICS SCARBOROUGH, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown